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Microspheres have been prepared from the resorbable linear polyester of β-hydroxybutyric acid (poly-
hydroxybutyrate, PHB) by the solvent evaporation technique and investigated in vitro and in vivo. 
Biocompatibility of the microspheres has been proved in tests in the culture of mouse fibroblast cell 
line NIH 3Т3 and in experiments on intramuscular implantation of the microspheres to Wistar rats for 
3 months. Tissue response to the implantation of polymeric microspheres has been found to consist in 
a mild inflammatory reaction, pronounced macrophage infiltration that increases over time, involving 
mono- and poly-nuclear foreign body giant cells that resorb the polymeric matrix. No fibrous capsules 
were formed around polymeric microparticles; neither necrosis nor any other adverse morphological 
changes and tissue transformation in response to the implantation of the PHB microparticles were 
recorded. The results of the study suggest that polyhydroxybutyrate is a good candidate for fabricating 
prolonged-action drugs in the form of microparticles intended for intramuscular injection.
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response.
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Introduction
Designing of controlled-release drug delivery 
systems is a promising and rapidly developing line 
of pharmacology. The main advantage of using 
drug delivery systems is that drug concentration in 
a patient’s blood and/or tissues can be maintained 
at a target level for an extended time (Amass 
et al., 1998; Kost and Langer, 2001). The most 
promising drug delivery systems seem to be 
biodegradable microspheres and microcapsules, 
which can be used to deliver a wide range of 
drugs; they can be injected into the bloodstream, 
subcutaneously, and intramuscularly and adapted 
for oral administration or inhalation (Freiberg 
and Zhu, 2004). The principal requirement for 
fabricating prolonged-action controlled-release 
drug delivery systems is availability of an 
appropriate material, which must be absolutely 
harmless to an organism and possess the necessary 
physical-mechanical and biomedical properties, 
including degradability in biological media. At the 
present time, the most widely used and actively 
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developed bioresorbable materials are polymers 
of monocarboxylic acid derivatives (polylactides 
and polyglycolactides), which have recently been 
joined by linear polyesters of microbiological 
origin – polyhydroxyalkanoates (PHAs) (Amass 
et al., 1998; S. Williams and Martin, 2002).
It has been shown that PHAs can be 
used to fabricate various items for medicine: 
surgery, transplantology, tissue engineering, and 
pharmacology (Anderson, 1988, 1997). One of 
the main tasks facing those investigating new 
biomaterials is to prove that they are absolutely 
biocompatible with and harmless to the host 
organism. Some researchers investigating 
PHAs such as polyhydroxybutyrate (PHB) and 
hydroxybutyrate/hydroxyvalerate copolymers 
(PHB/PHV) reported their cytotoxicity in animal 
cell cultures in vitro (Freiberg and Zhu, 2004) and 
slight inflammatory and pyrogenic reactions in 
animals during in vivo experiments (Gogolewski 
et al., 1993b). In recent years in vivo studies were 
conducted to evaluate biocompatibility of new 
PHAs (incorporating hydroxyhexanoate) (Qu 
et al., 2006). However, inflammation and other 
undesirable reactions to the tested biomaterials 
can also be related to their chemical composition, 
a particular implantation site, and the degree of 
chemical purity of the material. 
Literature reports show that it is not 
uncommon to use commercially available polymers 
in biomedical studies of PHAs (Williams et al., 
1999). The level of endotoxins in them can reach 
120 U/g (Sadian et al., 2000; Sevastianov et al., 
1990) due to the presence of microbial cell debris, 
which contains lipopolysaccharides and other 
complexes capable of causing negative reactions 
in cells in the in vitro systems and pyrogenic 
reactions in vivo (Sevastianov, 1990; Dobrova 
et al.,1991). We have developed a procedure for 
synthesis, recovery and purification of PHAs to 
prepare polymer specimens that would not contain 
organic impurities of protein, carbohydrate or 
lipid nature. Experiments with two PHA types 
– polyhydroxybutyrate (PHB) and copolymers of 
hydroxybutyric and hydroxyvaleric acids (PHBV) 
– in cultures of animal cells of various origins 
(fibroblasts, hepatocytes, and endothelial cells) did 
not show any negative influence of these PHAs, 
which directly contacted the cultured cells, on 
the cells. In experiments with laboratory animals 
biocompatibility of these polymers was proven 
at the cell (Stasishina avd Volova, 1996), tissue 
(Volova and Kalacheva, 1996a), and organism 
(Volova et al., 1996b) levels.
The biocompatibility of polyhydroxybutyrate 
(PHB, the most widespread and best studied PHA) 
has been confirmed in vitro, in cultures of cells of 
various origins (Volova, 2004; Saad et al., 2000; 
Shishatskaya et al., 2004a). Rather few results 
have been reported on in vivo biocompatibility 
of PHB, including data on local tissue reaction to 
polyhydroxybutyrate and poly(hydroxybutyrate/
hydroxyvalerate) implants (Gogolewski et 
al., 1993b; Shishatskaya and Volova, 2004b). 
However, those investigations were performed 
using large implants, in the form of sutures, 
film grafts or pins (Williams and Martin, 2002; 
Qu et al., 2006). It is well-known, though, that 
biocompatibility of biomaterials depends not 
only on the chemical structure and purity of 
the specimens but, to a large extent, on the size 
and shape of the implant (Anderson and Shive, 
1997).
Microspheres are considered to be the best 
form for injection-delivered prolonged-action 
drugs. However, microspheres, though containing 
a small amount of biomaterial, have a large 
surface area and, being injected subcutaneously or 
intramuscularly, come in contact with extensive 
area inside the host organism, which can cause 
stronger tissue reaction (Anderson and Shive, 
1997; Vospaleniye, 1995).
The purpose of this study was to test 
polyhydroxybutyrate microparticles for 
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cytotoxicity in vitro, in fibroblast culture, and 
to investigate tissue response to intramuscular 
implantation of PHB in vivo. 
  Materials and methods
2.1. Preparation of pure PHB polymer
The tested material was the PHB samples 
synthesized by the bacterium Ralstonia eutropha 
B5786 (Mw 340 000 Da, crystallinity 70-78%). 
The strain is registered in the Russian Collection of 
Industrial Microorganisms. The culture technique 
was described elsewhere (Volova and Kalacheva, 
1996a). PHB is extractable from bacterial biomass 
due to its ability to dissolve in organic solvents 
and to be then precipitated by alcohols. PHB was 
extracted from bacterial biomass with chloroform 
and precipitated with ethanol. The extraction of 
PHB from biomass was conducted in several 
stages. In the first stage, to partially destroy the 
cell wall and attain a fuller extraction of lipids, 
the bacterial biomass was centrifuged (for 15 min 
at 6000 rpm), collected, and covered with ethanol, 
pH 10.5-11.0 (0.5-0.7 g KOH/L ethanol). The 
sample was boiled using a backflow condenser 
for 30 min. Then the alcohol was removed, the 
biomass was covered with 86% ethanol and 
separated from alcohol by centrifuging. In the 
next stage the partly destroyed and defatted 
biomass was covered with chloroform and boiled 
for 30-40 min using a water bath with a backflow 
condenser. The sample was cooled and placed 
into a funnel to separate the chloroform extract 
of the polymer from the biomass. After separation 
of the phases, the polymer was precipitated by 
adding ethanol as a reagent. The procedure of re-
dissolution and further precipitation of polymer 
was repeated several times to prepare specimens 
that would not contain organic impurities of 
protein, carbohydrate or lipid nature. All the 
organic solvents used in the procedure were 
preliminarily distilled to remove impurities. We 
have previously shown that this procedure can 
be used to prepare high-purity PHB specimens, 
which would not contain any organic impurities 
– components of bacterial biomass – and would 
exhibit excellent biocompatibility characteristics, 
allowing them to contact blood (Sevastianov 
et al., 2003). The trademark of the material is 
Bioplastotan (Trademark “BIOPLASTOTAN”. 
Registration Certificate № 315652). 
2.2. Preparation of microspheres
PHA-based microspheres were prepared 
by the solvent evaporation technique, using a 
triple emulsion. 600 mg of the polymer (PHB) 
and 200 mg of polyethylene glycol (PEG40, 
molecular mass 40 kDa) were dissolved in 10 ml 
of dichloromethane at 40°C. Then, 1 ml of a 6% 
gelatin solution (40°C) was added and the mixture 
was shaken vigorously. The resulting water/oil (W/
O) double emulsion was allowed to cool to room 
temperature and, then, it was gradually poured 
into 150 ml of a 0.5% PVA solution, which was 
stirred with a three-blade propeller (at 700 rpm, 
for 20 min), to obtain a triple (water/oil/water, W/
O/W) emulsion. The emulsion was continuously 
mixed mechanically for 24 h, until the solvent 
was completely evaporated. Microspheres were 
collected by centrifuging (at 10 000 rpm, for 5 
min), rinsed 7-8 times in distilled water, and freeze 
dried in an LS-500 lyophilic dryer (Russia). 
2.3. Microspheres characterization
The size (number and volume weight mean 
diameter) and the size distribution of microspheres 
suspended in water were determined with an 
optical particle sizer Particle counter CASY 
TTC (Scharle system GmbH, Germany). Water 
was used as eluent. The microstructure of film 
surfaces was analyzed by electron microscopy. 
The samples were placed on the microscopic 
stage, coated with carbon and aluminum in a JEE-
4C vacuum evaporator and studied using a JEM-
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100C electron microscope with an EM-ASID-4 
raster attachment (Japan).
2.4. In vitro cytotoxicity of microspheres 
After sterilization, microspheres were tested 
for cytotoxicity towards the growth, morphology 
and metabolism of fibroblasts. The cytotoxicity 
test was conducted according to the ISO 10993 
standard. MEM Elution-Test on Extracts was 
conducted according to the ISO 10993-5 standard: 
in this study, 100 mg of the dry microspheres 
(equals at least 120 cm2) were extracted at 37 °C 
for 24 h in 20 ml Minimum essential Medium 
(MEM) supplemented with 10% fetal calf 
serum. 60 cm2 of industrial red rubber extract 
was a positive control;  60 cm2 of polystyrene 
“Greiner bio-one” was used as a negative control. 
An extract was prepared from the test material, 
which was then placed on cell monolayers. The 
cells were examined for morphologic changes 
and cytolysis to determine a toxicity score. The 
objects used were cultured cells: mouse fibroblast 
cell line NIH 3Т3, which belongs to the least 
transformed cell lines and retains many features of 
normal diploid cells. Fibroblasts of line NIH 3Т3 
were cultured in DMEM medium supplemented 
with 10% FCS (RPA “Vector”, Novosibirsk), 1.0 
mM L-glutamine, 10 mM HEPES, and 100 µg/
ml kanamycin sulfate (BDSL, UK). Cells were 
cultured in a humidified atmosphere at 5% CO2 
at 37°C. The duration of experiments ranged from 
4 h to 3 days. The cell count increased after the 
cells were passed two or three times using 0.2% 
collagenase solution diluted with a 0.02% versene 
solution. All stages were conducted under sterile 
conditions. After exposure to the extract for 72 h at 
37°C the medium was removed, leaving a film of 
medium in each well, and the cells were examined 
and scored microscopically for cytotoxic effects: 
confluency of the monolayer and change of 
cellular morphology. 
For cytological investigations, fixed and 
incompletely dried cells were Giemsa stained in a 
standard Jurr 65500 buffer at pH 6.8 and examined 
under a microscope with an H190/1.30 immersion 
objective and a PKIOX ocular. Preliminarily, cell 
viability was estimated by live staining with trypan 
blue (0.5% stain solution in 0.85% NaCl). Cell 
proliferation was measured at 3 days using 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) assay (Freshney, 2000). 800 µl 
serum free medium and 80 µl MTT solution (5 
mg MTT/ml in phosphate buffer saline) were 
quickly added to each sample and incubated for 3 
h at 37°C until formazan crystals were formed in 
cells. The medium and MTT were replaced by 800 
µl 10% sodium dodecyl sulfate (SDS) in 0.01 M 
HCl to dissolve the formazan crystals. Formazan 
concentrations were quantitatively determined 
by measuring the optical density (OD) at 570 nm 
against SDS solution blank. Each sample was 
measured thrice. The number of living cells in the 
culture was determined from the MTT absorbance 
standard curve.
2.5. Animal model
In vivo experiments were conducted on 
sexually mature female Wistar rats (200-240 g 
each). The rats were kept in a vivarium and fed 
a standard diet in accordance with the directive 
“Using animals in space biology and medical 
studies” (Genin et al., 2001). As control, intact 
animals were used.
Sterile microspheres (20 mg in 0.3 ml of a 
physiological saline) were injected intramuscularly 
into the femurs of the rats. At 24 h after injection 
and then every week, three animals were sacrificed 
by using an overdose of diethyl ether as volatile 
anesthetic. 
The general tissue reaction to implanted 
microspheres was investigated using conventional 
histological techniques. The microspheres were 
removed with excess surrounding tissue; the 
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samples were fixed in 10% formalin and embedded 
in paraffin; 5-10 μm thick microtome sections 
were stained with hematoxylin and eosin.
To prepare semithin sections, tissue samples 
were fixed in 2.5% glutaraldehyde in 0.1M 
cacodylate buffer at pH 7.2; then they were 
additionally fixed in a 1% OsO
4
 solution in the 
same buffer. The samples were dehydrated in 
graded series of ethanol and in acetone; then 
they were embedded in Epon 812-Araldite M 
resin (“Serva”). Semithin (1.5 μm thick) sections 
were cut using a Reichert Um-03 ultramicrotome 
(Austria) and then stained with 1% methylene blue. 
A Carl Zeiss Image Analysis System (Germany) 
was used for viewing microscopic images and 
analyzing morphometric characteristics of 
sections (ocular 10, objectives 10 and 40). The 
slides were evaluated for intensity and duration 
of inflammation, infiltration of cells at the site of 
microspheres injection, and the state of implanted 
microspheres. Assessment of the activity of cell 
elements was based on their average number in 
the field of view, with 10 fields of view analyzed. 
2.6. Statistics
All measurements in the in vitro tests were 
made at least in 2 experiments. Statistical analysis 
of the results was made using the standard software 
package of Microsoft Excel. Arithmetic means 
and standard deviations were found. Significant 
differences between mean values in control and 
treatment groups were tested using Student’s t 




The microspheres were of regular spherical 
shape and had a well-developed “wrinkled” 
porous surface; their diameters were significantly 
heterogeneous (Fig. 1). The size distribution 
of the microspheres injected intramuscularly 
in the rats was as follows (Fig. 2). The fraction 
of the microspheres of diameter up to 2 μm 
amounted to 33.3±2.2%. Microspheres of this 
size are considered to be the best for injections 
(Dijkhuizen-Radersma et al., 2002). The fraction 
of the particles 2 to 10 μm in diameter constituted 
38±1.9% and the fraction of the particles larger 
than 10 μm – 29±2.3%. The largest of the harvested 
particles were of diameter 35 μm and their fraction 
did not exceed 3-5%. The microparticles used in 
the experiment were of mean diameter 10 μm and 
of volume 0.016 cm3.
3.2. Cytotoxity
Evaluations of growth and metabolic 
parameters of the fibroblast cell culture in the 
treatment group and in the positive and negative 
control groups are presented in the table.Mouse 
fibroblast cells (NIH 3T3 line) cultured in the 
presence of polymeric (PHB) microspheres 
extracts similarly to the negative control 
15
Fig.1 
Fig. 1. Micrographs of the microspheres prepared from polyhydroxybutyrate.
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(polystyrene extract) retained the morphology of 
normal cells, like those grown in the control, on 
polystyrene. Cell viability test, performed by the 
method of live staining with trypan blue, showed 
that 99.8±0.2% of the cultured cells did not 
incorporate the dye, i.e. remained highly viable, 
in contrast to the positive control (rubber extract), 
in which most of the cells died (table).
The doubling time of fibroblasts corresponded 
to the generation time of the cells cultured on 
standard medium and experimental culture were 
25.1±1.8 and 25±2 h; on negative and positive 
controls -24.9±2.1 and 168±21.3 The MTT test 
did not indicate any toxic effect of the polymer 
extract on the metabolic activity of fibroblasts, 
either. Cell concentration of the experimental 
culture was comparable to those of the negative 
control and the standard medium culture (190±23 
× 106), and that was almost an order of magnitude 
higher than in the positive control (200±24 × 105). 
It is well-known that only active dehydrogenases 
of living cells will convert MTT into insoluble 
formazan crystals. 
Our investigations showed that extracts of 
polymeric PHB microparticles did not produce 
any toxic effect on proliferation and metabolic 
activity of mouse fibroblast cell line NIH 3Т3. The 
biocompatibility of the polymeric microparticles 
was subsequently investigated in the long-duration 
in vivo experiment. 
3.3. In vivo reaction
All animals in the treatment group, which 
had been injected with a microspheres suspension, 
were healthy and ate well. Their body mass and 
masses of their internal organs were similar to 
those of the rats in the control group. 
At 24 h after the injection of polymeric 
microparticles, the microscopic picture at the 
injection site was characterized by a slight tissue 
Fig. 2. The size distribution of the microspheres injected intramuscularly in the rats
– 72 –
Ekaterina I. Shishatskaya, Olga N. Voinova, Anastasya V. Goreva… Biocompatibility of Polyhydroxybutyrate Microspheres…
edema and leukocyte infiltration. The cluster of 
microspheres injected intramuscularly may be 
considered as an open porous implant. 
The nature and extent of the tissue reaction to 
the implant is known (Anderson and Shive, 1997; 
Serov, 1995) to be characterized by the presence 
of specific cell types. After injury due to surgical 
intervention and implantation of the material or a 
tested item, aseptic tissue inflammation develops 
at the site of implantation. It is usually divided into 
several phases: alteration (injury), exudation, and 
proliferation; the last phase is at the same time the 
first phase of tissue repair. The phases of exudation 
and proliferation are sometimes subdivided into 
neutrophil, macrophage, and fibroblast phases. 
The neutrophil phase occurs during the first 
few hours of implantation: polymorphonuclear 
leukocytes (PMNs) migrate from the vessels to 
the site of damage, surround it, and, after 6-12 h, 
form a leukocyte barrier. The lifetime of PMNs 
is short; within 24 h neutrophilic leukocytes stop 
migrating and their decomposition is started.
In our experiment, in 24 h after the injection 
of PHB microparticles, the initial inflammatory 
response was started as could be seen from the 
presence of polymorphonuclear leukocytes (up to 
20-25 in the field of view). This tissue reaction 
was of short duration; after 1 week the intensity 
of polymorphonuclear leukocytes decreased 
significantly. The low intensity of leukocytes 
during that time suggests that tissue reaction to the 
implantation of polymeric microparticles can be 
described as a mild inflammatory response. After 
1 week of implantation, we observed infiltration 
of fibroblast cell elements and formation of a 
thin fibrous capsule at the interface between the 
microspheres and the intact muscular tissue, as a 
foreign body reaction of the tissue.
The foreign body reaction is expressed by the 
amount of macrophages at the microspheres/tissue 
interface (Anderson and Shive, 1997). In this phase 
(the macrophage phase), macrophages penetrate 
into the leukocyte barrier and phagocytize cell 
detritus and degradation products from the tissue 
and implanted material. Macrophages surround 
the foreign body and form neutrophil-macrophage 
→ macrophage → macrophage-fibroblast barriers, 
which prevents the formation of granulation 
tissue (Marchant et al., 1983; Zhao et al., 1992; 
Kao et al., 1994). When biodegradable materials 
are implanted, the macrophage response, which 
follows the neutrophil response, increases 
rather than decreases. The reason for this is 
that macrophages and foreign body giant cells 
phagocytize and resorb biodegradable materials. 
The main contribution to the formation of foreign 
body giant cells (FBGCs) is made by macrophages, 
which phagocytize the implanted material. It is 
well-known that FBGCs, formed on the surface of 
or around the particles of the implanted material 
by the fusion of macrophages and by nuclear 
division of macrophages without cytokinesis, 
resorb the material (Khrushchev et al., 1978; 
Rhee et al., 1979; Anderson, 2001). This has been 
demonstrated in numerous studies of polymeric 
microparticles prepared from various resorbable 
materials: polyethylene glycol (Dijkhuizen-
Radersma et al., 2002), polylactides and lactide/
glycolide copolymers (Kang and Singh, 2005), 
and poly(methylidene malonate 2.1.2 (Fournier, 
et al., 2006).
It has been reported that in some PHAs, 
including 3- and 4-polyhydroxybutyrate, in 
vivo resorption involves active participation of 
phagocytic macrophages and foreign body giant 
cells (FBGCs) (Williams and Martin, 2002). In 
our recent study we investigated tissue response 
to polyhydroxybutyrate monofilament sutures 
used to close muscle-fascial wounds and found 
out that macrophages played an important role in 
the tissue repair response, phagocytizing injured 
cells and tissues and polymer particles and 
degradation products (Shishatskaya et al., 2004a). 
The reaction of tissues to polyhydroxybutyrate 
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implants was comparable in intensity and length 
to their reaction to silk and was considerably 
less pronounced than their reaction to resorbable 
catgut.
Figure 3 shows the tissue at the microspheres 
implantation site at 2 weeks. One can see 
mononuclear secretory-phagocytic macrophages 
and a few FBGCs with 2-3 nuclei.
Besides phagocytosis, macrophages 
initiate the formation of granulation tissue. The 
granulation tissue response is characterized 
by fibroblast infiltration and the development 
of blood capillaries (Anderson, 1988). If an 
implant is made from non-resorbable material, 
a thick fibrous capsule is usually formed around 
it. If biocompatible and biodegradable implants 
are used, the tissue response may not involve 
the formation of a thick fibrous capsule or, 
if the capsule is formed, it is later involuted 
(Shishatskaya et al., 2004a). At 2 weeks, the cluster 
of the injected microspheres was encapsulated 
with thin connective tissue (Fig. 3). At that time, 
the percentage of large particles (over 10-15μm) 
in the cluster of microspheres was significantly 
reduced and did not exceed 14% in the field of 
view. Active fibroblast elements were identified in 
the structure of the thin capsule; its mean thickness 
was not more than 50-60 μm; it consisted of 4-6 
fibroblast layers. The reaction was almost 3 times 
less intensive than the reaction of muscular tissue 
to the implantation of sutures that we reported 
earlier (Shishatskaya et al., 2004a). This result 
is in good agreement with the data reported by 
Fournier et al. (Fournier et al., 2006), who found 
that the intramuscularly injected microspheres 
cluster was isolated from the muscular tissue by 
a very thin fibrous capsule, which was much less 
developed than the capsule formed in the event 
of subcutaneous injection. At the site of injection 
of PHB microparticles, the newly formed tissue 
was significantly vascularized, indicating high 
biocompatibility of the polymeric microspheres 
and favorable tissue reaction. The area of the 
edema at the implantation site was considerably 
decreased, there were no necrotic areas. There 
were a few leukocytes among the microspheres. 
We recorded an increase in the number of 
mature secretory-phagocytic macrophages (up to 
6.36±0.42 in the field of view) on the inner side 
of the capsule adhering to the implant and at the 
cluster of the microspheres. 
Later in the experiment we observed more 
intensive macrophage infiltration at the site of 
injection of the microspheres; the amounts of both 
Fig. 3. Microscopic picture of tissue at the site of polyhydroxybutyrate microspheres implantation  
(2 weeks after implantation). Mp stands for microparticles, fc – fibrous capsule. The bar is 20 µm
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mononuclear macrophages and FBGCs increased. 
At 5 weeks, the number of mono- and poly-
nuclear macrophages at the site of implantation of 
the microspheres increased (Fig. 4a). The fraction 
of large particles became smaller and did not 
exceed 4-5% of the total amount of the particles 
in the field of view, suggesting that the polymeric 
matrix was being degraded. FBGCs with 6-8 
nuclei were observed to aggregate around large 
(more than 10 μm in diameter) microspheres. At 
the interface between the intact muscular tissue 
and the microspheres there still was a fibrous 
capsule, though very thin, consisting of 2-3 layers 
of mature fibroblasts (Fig. 4b). The macrophage 
response grew more intense at 7-9 weeks; the 
number of FBGCs increased and so did the 
number of their nuclei. At the site of implantation 
of the microspheres we clearly saw macrophages 
grouped around large microparticles. In some cases 
we could see penetration of cell elements into the 
surface matrix of the microspheres and degraded 
(resorbed) parts around the circumference of the 
particles at the implant/tissue interface (Fig. 5a), 
which indicated that the polymeric matrix of the 
microparticles was being degraded. There were no 
fibrous capsules either at the microspheres/tissue 
interface or around any of the microspheres. This 
is a very important fact because the fibrous capsule 
around a polymeric particle could significantly 
influence the release behavior of the encapsulated 
drug and resorption of the polymeric matrix.
At the end of the experiment (11-12 weeks), 
the tissue reaction remained essentially the same: 
we observed pronounced macrophage infiltration 
with a large number of poly-nuclear FBGCs, 
which either surrounded polymeric particles 
or were grouped around a cluster of smaller 
microparticles; there were rather large fusions of 
FBGCs with 10-12 and even more nuclei (Fig. 5a). 
There were no fibrous capsules at the interface 
between the intact muscular tissue and the 
cluster of the microspheres. In some parts of the 
microspheres cluster there was polymeric detritus, 
as a degradation product of larger particles. The 
fraction of microspheres larger than 10-15 μm 
in the field of view significantly decreased (to 
about 2-3%) and fragmented microparticles were 
seen (Fig. 5b). For quite a long time, however, 
most of the microspheres persisted in the tissue 
undegraded, suggesting that in vivo bioresorption 
of microparticles must be rather a long process, 
which makes polyhydroxybutyrate a good 
candidate for fabricating a prolonged-action drug 
form intended for intramuscular injection.
Fig. 4. Microscopic picture of tissue at the site of polyhydroxybutyrate microspheres implantation  
(5 weeks after implantation). Mp stands for microparticles, mph – macrophages,  
FBGCs – foreign body giant cells, tf – tissue fibers, fc – fibrous capsule. The bar is 20 µm
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Conclusion
In vitro and in vivo experiments showed that 
polyhydroxybutyrate microspheres of diameter 
from 0.9 to 35.0 μm were biocompatible; they 
neither inhibited growth and metabolic activity 
of fibroblasts nor caused negative response in 
animals that were intramuscularly injected with 
them. The tissue response to the implantation 
of polyhydroxybutyrate microparticles was 
characterized by mild inflammatory reaction of 
short duration, pronounced and ever increasing 
macrophage infiltration involving foreign body 
giant cells that resorbed the polymeric matrix, 
and the granulation response, involving the 
formation of a highly vascularized thin fibrous 
capsule at the microspheres/tissue interface, 
which was resorbed after several weeks of 
implantation. No fibrous capsules were formed 
around polymeric microparticles; neither necrosis 
nor any other adverse morphological changes 
and tissue transformation in response to the 
implantation of the polymeric microparticles 
were recorded. The results of the study suggest 
that polyhydroxybutyrate is a good candidate for 
fabricating prolonged-action drugs in the form 
of microparticles intended for intramuscular 
injection.
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